第二代抗精神病药物和心血管不良影响:为初级保健医学制定基于证据的建议
Sana Borda1, Anh-Dao Lee2, Paul F Bell3
1St Margaret's Hospital, Pittsburgh, PA.
HCA healthcare journal of medicine
|January 10, 2025
概括
初级保健医生可以管理与第二代抗精神病药物 (SGA) 相关的心血管风险. 现在可以提供基于证据的建议,以指导PCP在使用SGA的患者中监测和减轻潜在的心脏毒性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心脏病学 心脏病学
- 初级医疗保健医学 一级医疗保健医学
背景情况:
- 第二代抗精神病药物 (SGA) 是由初级保健医生 (PCP) 用于各种精神疾病的广泛处方.
- SGA与不良心血管影响有关,但PCP缺乏基于证据的指导来管理这种风险.
- 该项目解决了针对初级保健的SGA和心脏毒性建议的需求.
研究的目的:
- 为PCP制定基于证据的建议,关于使用SGA及其相关心血管风险.
- 综合目前关于SGA心脏毒性的证据.
- 为初级保健机构的风险评估和管理提供实际指导.
主要方法:
- 在PubMed,PubMed Central和AccessMedicine中使用与SGA和心血管疾病相关的术语进行了系统的文献搜索.
- 系统性审查和元分析被优先考虑,并使用多种系统性审查-2 (AMSTAR-2) 评估工具进行质量评估.
- 用高质量和中等质量的研究来制定PCP的建议.
主要成果:
- 七个系统审查和元分析符合质量标准.
- 这种SGA与不良心脏事件有关,包括QT间隔延长,心律失常,心肌梗塞和心跳动等.
- 心脏代谢疾病也被确定为潜在的风险.
结论:
- 心血管风险与SGA相关,需要对心脏毒性进行查和监测.
- 对于大多数患者来说,SGA的好处通常超过风险.
- 有效的SGA风险降低策略可以在初级保健中实施.
相关概念视频
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
707
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
707
Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
Adrenergic Antagonists: ɑ and β-Receptor Blockers
405
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
405
Antipsychotic Drugs: Typical and Atypical Agents
153
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
153
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.0K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.0K
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K


